Medical Devices · Healthcare
CEO, Board Member, Chairman
2023-04-24–present
Board Member
Butterfly Network, Inc. (BFLY)Chairman
Butterfly Network, Inc. (BFLY)Equibles does not estimate personal net worth.
Get an email with a short summary when Butterfly Network, Inc. publishes a filing, an earnings call transcript or a press release.
Get BFLY alertsJoseph DeVivo is recorded as Board Member and Chairman at Butterfly Network, Inc. (BFLY) since April 24, 2023 and CEO at Butterfly Network, Inc. (BFLY). The newest filing on record that lists Joseph DeVivo as CEO at Butterfly Network, Inc. (BFLY) is dated April 27, 2026. Butterfly Network, Inc. reported in an 8-K filed April 24, 2023 that Joseph DeVivo was appointed Chairman of the Board, effective April 24, 2023. Butterfly Network, Inc. reported in an 8-K filed April 24, 2023 that Joseph DeVivo was appointed President and Chief Executive Officer, principal executive officer, effective April 24, 2023. The proxy statement of Butterfly Network, Inc. reports total compensation of $6,382,814 for Joseph DeVivo in fiscal 2025, including a base salary of $900,300. Disclosed compensation is on record for 3 fiscal years. Joseph DeVivo has spoken on 12 earnings calls across 1 company, most recently for Butterfly Network, Inc. on July 30, 2026. Butterfly Network, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Butterfly Network, Inc. includes Jonathan Rothberg (CEO, Chairman and Board Member), Joseph M. DeVivo (CEO, Chairman and Board Member), Todd Fruchterman (CEO and Board Member) and 7 others.
“the Board approved the appointment of Joseph DeVivo as President and Chief Executive Officer, principal executive officer, and Chairman of the Board, effective as of April 24, 2023 (the "Effective Date").”
“the Board approved the appointment of Joseph DeVivo as President and Chief Executive Officer, principal executive officer, and Chairman of the Board, effective as of April 24, 2023 (the "Effective Date").”
“So good morning, everyone, and thank you for joining our second quarter 2026 earnings call. What a great quarter it was. We closed above the top end of guidance, delivered record revenues, gross margins, and adjusted EBITDA, all above where we thought we'd end up.”
“Ultrasound has many use cases which are growing rapidly in both scientific and clinical importance. As I mentioned last quarter, if you scan publications in Nature over the past year, you'll find a body of literature growing around functional ultrasound.”
“Good morning, everyone, and thank you for joining our fourth quarter and full year 2025 conference call. I'm pleased to announce that our fourth quarter revenues came in at $31.5 million, growing 41% year-over-year.”
“A replay of the event will also be available on the page following the call i will now like to turn the call over to joe joe thanks heather and good morning everyone and thanks for getting up early with us on a friday the second quarter marked the first full quarter to anniversary our butterfly iq3 launch in the prior…”
“We're pleased to deliver another quality quarter in line with our guidance of 20% growth and making meaningful profitability improvement with gross margins of 63% while improving adjusted EBITDA loss from $13.2 million a year ago to $9.1 million now.”
2023-04-24–present
2023-04-24–present
Start not stated–present
Last confirmed April 27, 2026
Medical Devices · Healthcare
CEO, Board Member, Chairman
2023-04-24–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Butterfly Network, Inc. (BFLY) | President and Chief Executive Officer | $900,300 | $6,382,814 |
| 2024 | Butterfly Network, Inc. (BFLY) | President and Chief Executive Officer | $875,000 | $5,492,289 |
| 2023 | Butterfly Network, Inc. (BFLY) | President and Chief Executive Officer | $588,942 | $10,808,618 |